Deals· August 6, 2026 · 13 min read
Gilead's $7.8B Arcellx Acquisition: Anito-Cel Deal Anatomy
By Ran Chen#Gilead Sciences#Arcellx#anito-cel
Gilead Sciences portfolio, Kite Pharma cell therapy franchise, oncology acquisitions, and commercial launches.